-
1
-
-
79952232216
-
Global cancer statistics
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E, &, Forman D, (2011) Global cancer statistics. CA A Cancer J Clin 61, 69-90.
-
(2011)
CA A Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
2
-
-
82155164396
-
Treatment strategies in gastric cancer
-
Meyer HJ, &, Wike H, (2011) Treatment strategies in gastric cancer. Dtsch Arztebl Int 108, 698-706.
-
(2011)
Dtsch Arztebl Int
, vol.108
, pp. 698-706
-
-
Meyer, H.J.1
Wike, H.2
-
3
-
-
80054717683
-
The role of chemotherapy in metastatic gastric cancer
-
Pasini F, Fraccon AP, &, De Manzoni G, (2011) The role of chemotherapy in metastatic gastric cancer. Anticancer Res 31, 3543-3554.
-
(2011)
Anticancer Res
, vol.31
, pp. 3543-3554
-
-
Pasini, F.1
Fraccon, A.P.2
De Manzoni, G.3
-
4
-
-
40749153540
-
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial
-
Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, et al,. (2008) S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9, 215-221.
-
(2008)
Lancet Oncol
, vol.9
, pp. 215-221
-
-
Koizumi, W.1
Narahara, H.2
Hara, T.3
Takagane, A.4
Akiya, T.5
Takagi, M.6
Miyashita, K.7
Nishizaki, T.8
Kobayashi, O.9
Takiyama, W.10
-
5
-
-
0035400270
-
Mechanisms of resistance to cisplatin
-
Kartalou M, &, Essigmann JM, (2001) Mechanisms of resistance to cisplatin. Mutat Res 478, 23-43.
-
(2001)
Mutat Res
, vol.478
, pp. 23-43
-
-
Kartalou, M.1
Essigmann, J.M.2
-
6
-
-
35348827736
-
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy
-
Hall MD, Okabe M, Shen DW, Liang XJ, &, Gottesman MM, (2008) The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol Toxicol 48, 495-535.
-
(2008)
Annu Rev Pharmacol Toxicol
, vol.48
, pp. 495-535
-
-
Hall, M.D.1
Okabe, M.2
Shen, D.W.3
Liang, X.J.4
Gottesman, M.M.5
-
7
-
-
84876096250
-
Targeting survivin in cancer
-
Altieri DC, (2013) Targeting survivin in cancer. Cancer Lett 332, 225-228.
-
(2013)
Cancer Lett
, vol.332
, pp. 225-228
-
-
Altieri, D.C.1
-
8
-
-
84888315981
-
TFF3 and survivin expressions associate with a lower survival rate in gastric cancer
-
in press. doi: 10.1007/s10238-012-0210-9.
-
Meng JR, Tang HZ, Zhou KZ, Shen WH, &, Guo HY, (2012) TFF3 and survivin expressions associate with a lower survival rate in gastric cancer. Clin Exp Med in press. doi: 10.1007/s10238-012-0210-9.
-
(2012)
Clin Exp Med
-
-
Meng, J.R.1
Tang, H.Z.2
Zhou, K.Z.3
Shen, W.H.4
Guo, H.Y.5
-
9
-
-
0037267333
-
Validating survivin as a cancer therapeutic target
-
Altieri DC, (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3, 46-54.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 46-54
-
-
Altieri, D.C.1
-
10
-
-
84880510067
-
Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation
-
Li T, Liu Z, Jiang K, &, Ruan Q, (2013) Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation. Cancer Lett 337, 276-284.
-
(2013)
Cancer Lett
, vol.337
, pp. 276-284
-
-
Li, T.1
Liu, Z.2
Jiang, K.3
Ruan, Q.4
-
11
-
-
84879289773
-
Suppression of survivin induced by BCR-ABL/JAK2/STAT3 pathway sensitizes Imatinib-resistant CML cells to different cytotoxic drugs
-
Stella S, Tirrò E, Conte E, Stagno F, Di Raimondo F, Manzella L, &, Vigneri P, (2013) Suppression of survivin induced by BCR-ABL/JAK2/STAT3 pathway sensitizes Imatinib-resistant CML cells to different cytotoxic drugs. Mol Cancer Ther 12, 1085-1098.
-
(2013)
Mol Cancer Ther
, vol.12
, pp. 1085-1098
-
-
Stella, S.1
Tirrò, E.2
Conte, E.3
Stagno, F.4
Di Raimondo, F.5
Manzella, L.6
Vigneri, P.7
-
12
-
-
77957194642
-
A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy
-
Cheung CH, Sun X, Kanwar JR, Bai JZ, Cheng L, &, Krissansen GW, (2010) A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy. Cancer Cell Int 10, 36.
-
(2010)
Cancer Cell Int
, vol.10
, pp. 36
-
-
Cheung, C.H.1
Sun, X.2
Kanwar, J.R.3
Bai, J.Z.4
Cheng, L.5
Krissansen, G.W.6
-
13
-
-
40949142209
-
The role of hypoxia-inducible factors in tumorigenesis
-
Rankin EB, &, Giaccia AJ, (2008) The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15, 678-685.
-
(2008)
Cell Death Differ
, vol.15
, pp. 678-685
-
-
Rankin, E.B.1
Giaccia, A.J.2
-
14
-
-
49649115935
-
Hypoxia-inducible transcription factor-2α in endothelial cells regulates tumor neovascrularization through activation of ephrin A1
-
Yamashita T, Ohneda K, Nagano M, Miyoshi C, Kaneko N, Miwa Y, Yamamoto M, Ohneda O, &, Fujii-Kuriyama Y, (2008) Hypoxia-inducible transcription factor-2α in endothelial cells regulates tumor neovascrularization through activation of ephrin A1. J Biol Chem 283, 18926-18936.
-
(2008)
J Biol Chem
, vol.283
, pp. 18926-18936
-
-
Yamashita, T.1
Ohneda, K.2
Nagano, M.3
Miyoshi, C.4
Kaneko, N.5
Miwa, Y.6
Yamamoto, M.7
Ohneda, O.8
Fujii-Kuriyama, Y.9
-
15
-
-
78349272461
-
HIF-1 and HIF-2 transcription factors - Similar but not identical
-
Loboda A, Jozkowicz A, &, Dulak J, (2010) HIF-1 and HIF-2 transcription factors-similar but not identical. Mol Cells 29, 435-442.
-
(2010)
Mol Cells
, vol.29
, pp. 435-442
-
-
Loboda, A.1
Jozkowicz, A.2
Dulak, J.3
-
16
-
-
77957786826
-
Hypoxia-inducible factor 1α determines gastric cancer chemosensitivity via modulation of p53 and NF-κB
-
Rohwer N, Dame C, Haugstetter A, Wiedenmann B, Detjen K, Schmitt CA, &, Cramer T, (2010) Hypoxia-inducible factor 1α determines gastric cancer chemosensitivity via modulation of p53 and NF-κB. PLoS ONE 5, e12038.
-
(2010)
PLoS ONE
, vol.5
-
-
Rohwer, N.1
Dame, C.2
Haugstetter, A.3
Wiedenmann, B.4
Detjen, K.5
Schmitt, C.A.6
Cramer, T.7
-
17
-
-
36949000697
-
Hypoxia-inducible factor-1α contributes to hypoxia-induced chemoresistance in gastric cancer
-
Liu L, Ning X, Sun L, Zhang H, Shi Y, Guo C, Han S, Liu J, Sun S, Han Z, et al,. (2008) Hypoxia-inducible factor-1α contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 99, 121-128.
-
(2008)
Cancer Sci
, vol.99
, pp. 121-128
-
-
Liu, L.1
Ning, X.2
Sun, L.3
Zhang, H.4
Shi, Y.5
Guo, C.6
Han, S.7
Liu, J.8
Sun, S.9
Han, Z.10
-
18
-
-
54949123005
-
Antisense hypoxia-inducible factor 1α gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma
-
Liu F, Wang P, Jiang X, Tan G, Qiao H, Jiang H, Krissansen GW, &, Sun X, (2008) Antisense hypoxia-inducible factor 1α gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma. Cancer Sci 99, 2055-2061.
-
(2008)
Cancer Sci
, vol.99
, pp. 2055-2061
-
-
Liu, F.1
Wang, P.2
Jiang, X.3
Tan, G.4
Qiao, H.5
Jiang, H.6
Krissansen, G.W.7
Sun, X.8
-
19
-
-
77954815583
-
Antisense HIF-1 prevents acquired tumour resistance to the anti-angiogenic drug angiostatin
-
Sun X, Vale M, Jiang X, Gupta R, &, Krissansen GW, (2010) Antisense HIF-1 prevents acquired tumour resistance to the anti-angiogenic drug angiostatin. Cancer Gene Ther 17, 532-540.
-
(2010)
Cancer Gene Ther
, vol.17
, pp. 532-540
-
-
Sun, X.1
Vale, M.2
Jiang, X.3
Gupta, R.4
Krissansen, G.W.5
-
20
-
-
79959550744
-
Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells
-
Wohlkoenig C, Leithner K, Deutsch A, Hrzenjak A, Olschewski A, &, Olschewski H, (2011) Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells. Cancer Lett 308, 134-143.
-
(2011)
Cancer Lett
, vol.308
, pp. 134-143
-
-
Wohlkoenig, C.1
Leithner, K.2
Deutsch, A.3
Hrzenjak, A.4
Olschewski, A.5
Olschewski, H.6
-
21
-
-
84864294365
-
HIF1α regulated expression of XPA contributes to cisplatin resistance in lung cancer
-
Liu Y, Bernauer AM, Yingling CM, &, Belinsky SA, (2012) HIF1α regulated expression of XPA contributes to cisplatin resistance in lung cancer. Carcinogenesis 33, 1187-1192.
-
(2012)
Carcinogenesis
, vol.33
, pp. 1187-1192
-
-
Liu, Y.1
Bernauer, A.M.2
Yingling, C.M.3
Belinsky, S.A.4
-
22
-
-
84875256838
-
Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells
-
Bai H, Ge S, Lu J, Qian G, &, Xu R, (2013) Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells. J Obstet Gynaecol Res 39, 555-563.
-
(2013)
J Obstet Gynaecol Res
, vol.39
, pp. 555-563
-
-
Bai, H.1
Ge, S.2
Lu, J.3
Qian, G.4
Xu, R.5
-
23
-
-
84879370462
-
HIF-1α knockdown by miRNA decreases survivin expression and inhibits A549 cell growth in vitro and in vivo
-
Li W, Chen YQ, Shen YB, Shu HM, Wang XJ, Zhao CL, &, Chen CJ, (2013) HIF-1α knockdown by miRNA decreases survivin expression and inhibits A549 cell growth in vitro and in vivo. Int J Mol Med 32, 271-280.
-
(2013)
Int J Mol Med
, vol.32
, pp. 271-280
-
-
Li, W.1
Chen, Y.Q.2
Shen, Y.B.3
Shu, H.M.4
Wang, X.J.5
Zhao, C.L.6
Chen, C.J.7
-
24
-
-
84878831559
-
Overcoming acquired resistance to anticancer therapy: Focus on the PI3K/AKT/mTOR pathway
-
Burris HA III, (2013) Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway. Cancer Chemother Pharmacol 71, 829-842.
-
(2013)
Cancer Chemother Pharmacol
, vol.71
, pp. 829-842
-
-
Burris III, H.A.1
-
25
-
-
84871675092
-
AKT as locus of cancer multidrug resistance and fragility
-
Radisavljevic Z, (2013) AKT as locus of cancer multidrug resistance and fragility. J Cell Physiol 228, 671-674.
-
(2013)
J Cell Physiol
, vol.228
, pp. 671-674
-
-
Radisavljevic, Z.1
-
26
-
-
77951623315
-
Regulation of survivin by PI3K/Akt/p70S6K1 pathway
-
Zhao P, Meng Q, Liu LZ, You YP, Liu N, &, Jiang BH, (2010) Regulation of survivin by PI3K/Akt/p70S6K1 pathway. Biochem Biophys Res Commun 395, 219-224.
-
(2010)
Biochem Biophys Res Commun
, vol.395
, pp. 219-224
-
-
Zhao, P.1
Meng, Q.2
Liu, L.Z.3
You, Y.P.4
Liu, N.5
Jiang, B.H.6
-
27
-
-
84855661853
-
Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma
-
Jiao M, &, Nan KJ, (2012) Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma. Int J Oncol 40, 461-468.
-
(2012)
Int J Oncol
, vol.40
, pp. 461-468
-
-
Jiao, M.1
Nan, K.J.2
-
28
-
-
34548574823
-
YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone refractory prostate tumor xenografts
-
Nakahara T, Kita A, Yamanaka K, Mori M, Amino N, Takeuchi M, Tominaga F, Hatakeyama S, Kinoyama I, Matsuhisa A, et al,. (2007) YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone refractory prostate tumor xenografts. Cancer Res 67, 8014-8021.
-
(2007)
Cancer Res
, vol.67
, pp. 8014-8021
-
-
Nakahara, T.1
Kita, A.2
Yamanaka, K.3
Mori, M.4
Amino, N.5
Takeuchi, M.6
Tominaga, F.7
Hatakeyama, S.8
Kinoyama, I.9
Matsuhisa, A.10
-
29
-
-
84868691831
-
Thimerosal-induced apoptosis in mouse C2C12 myoblast cells occurs through suppression of the PI3K/Akt/survivin pathway
-
Li WX, Chen SF, Chen LP, Yang GY, Li JT, Liu HZ, &, Zhu W, (2012) Thimerosal-induced apoptosis in mouse C2C12 myoblast cells occurs through suppression of the PI3K/Akt/survivin pathway. PLoS ONE 7, e49064.
-
(2012)
PLoS ONE
, vol.7
-
-
Li, W.X.1
Chen, S.F.2
Chen, L.P.3
Yang, G.Y.4
Li, J.T.5
Liu, H.Z.6
Zhu, W.7
-
30
-
-
53549127988
-
CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation
-
Roca H, Varsos Z, &, Pienta KJ, (2008) CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation. J Biol Chem 283, 25057-25073.
-
(2008)
J Biol Chem
, vol.283
, pp. 25057-25073
-
-
Roca, H.1
Varsos, Z.2
Pienta, K.J.3
-
31
-
-
84874463929
-
Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma
-
Xiu P, Dong X, Dong X, Xu Z, Zhu H, Liu F, Wei Z, Zhai B, Kanwar JR, Jiang H, et al,. (2013) Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma. Cancer Sci 104, 375-382.
-
(2013)
Cancer Sci
, vol.104
, pp. 375-382
-
-
Xiu, P.1
Dong, X.2
Dong, X.3
Xu, Z.4
Zhu, H.5
Liu, F.6
Wei, Z.7
Zhai, B.8
Kanwar, J.R.9
Jiang, H.10
-
32
-
-
84866102548
-
YM155 reverses cisplatin resistance in head and neck cancer by decreasing cytoplasmic survivin levels
-
Kumar B, Yadav A, Lang JC, Cipolla MJ, Schmitt AC, Arradaza N, Teknos TN, &, Kumar P, (2012) YM155 reverses cisplatin resistance in head and neck cancer by decreasing cytoplasmic survivin levels. Mol Cancer Ther 11, 1988-1998.
-
(2012)
Mol Cancer Ther
, vol.11
, pp. 1988-1998
-
-
Kumar, B.1
Yadav, A.2
Lang, J.C.3
Cipolla, M.J.4
Schmitt, A.C.5
Arradaza, N.6
Teknos, T.N.7
Kumar, P.8
-
33
-
-
79957534572
-
Targeting hypoxia in cancer therapy
-
Wilson WR, &, Hay MP, (2011) Targeting hypoxia in cancer therapy. Nat Rev Cancer 11, 393-410.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 393-410
-
-
Wilson, W.R.1
Hay, M.P.2
-
34
-
-
10744231706
-
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
-
Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW, &, Giannakakou P, (2003) 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3, 363-375.
-
(2003)
Cancer Cell
, vol.3
, pp. 363-375
-
-
Mabjeesh, N.J.1
Escuin, D.2
Lavallee, T.M.3
Pribluda, V.S.4
Swartz, G.M.5
Johnson, M.S.6
Willard, M.T.7
Zhong, H.8
Simons, J.W.9
Giannakakou, P.10
-
35
-
-
77953158079
-
Distinct biological roles for the Akt family in mammary tumor progression
-
Dillon RL, &, Muller WJ, (2010) Distinct biological roles for the Akt family in mammary tumor progression. Cancer Res 70, 4260-4264.
-
(2010)
Cancer Res
, vol.70
, pp. 4260-4264
-
-
Dillon, R.L.1
Muller, W.J.2
-
36
-
-
27744432361
-
Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation
-
Belyanskaya LL, Hopkins-Donaldson S, Kurtz S, Simões-Wüst AP, Yousefi S, Simon HU, Stahel R, &, Zangemeister-Wittke U, (2005) Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation. Int J Cancer 117, 755-763.
-
(2005)
Int J Cancer
, vol.117
, pp. 755-763
-
-
Belyanskaya, L.L.1
Hopkins-Donaldson, S.2
Kurtz, S.3
Simões-Wüst, A.P.4
Yousefi, S.5
Simon, H.U.6
Stahel, R.7
Zangemeister-Wittke, U.8
-
37
-
-
3042743988
-
Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt
-
Yang L, Dan HC, Sun M, Liu Q, Sun XM, Feldman RI, Hamilton AD, Polokoff M, Nicosia SV, Herlyn M, et al,. (2004) Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res 64, 4394-4399.
-
(2004)
Cancer Res
, vol.64
, pp. 4394-4399
-
-
Yang, L.1
Dan, H.C.2
Sun, M.3
Liu, Q.4
Sun, X.M.5
Feldman, R.I.6
Hamilton, A.D.7
Polokoff, M.8
Nicosia, S.V.9
Herlyn, M.10
-
38
-
-
79955504184
-
Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice
-
Balasis ME, Forinash KD, Chen YA, Fulp WJ, Coppola D, Hamilton AD, Cheng JQ, &, Sebti SM, (2011) Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice. Clin Cancer Res 17, 2852-2862.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 2852-2862
-
-
Balasis, M.E.1
Forinash, K.D.2
Chen, Y.A.3
Fulp, W.J.4
Coppola, D.5
Hamilton, A.D.6
Cheng, J.Q.7
Sebti, S.M.8
-
39
-
-
84872803114
-
Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo
-
Wei Z, Jiang X, Liu F, Qiao H, Zhou B, Zhai B, Zhang L, Zhang X, Han L, Jiang H, et al,. (2013) Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo. Tumor Biol 34, 181-192.
-
(2013)
Tumor Biol
, vol.34
, pp. 181-192
-
-
Wei, Z.1
Jiang, X.2
Liu, F.3
Qiao, H.4
Zhou, B.5
Zhai, B.6
Zhang, L.7
Zhang, X.8
Han, L.9
Jiang, H.10
-
40
-
-
84877607377
-
Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells
-
Tanaka M, Kataoka H, Yano S, Ohi H, Kawamoto K, Shibahara T, Mizoshita T, Mori Y, Tanida S, Kamiya T, et al,. (2013) Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells. BMC Cancer 13, 237.
-
(2013)
BMC Cancer
, vol.13
, pp. 237
-
-
Tanaka, M.1
Kataoka, H.2
Yano, S.3
Ohi, H.4
Kawamoto, K.5
Shibahara, T.6
Mizoshita, T.7
Mori, Y.8
Tanida, S.9
Kamiya, T.10
-
41
-
-
84873307557
-
STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells
-
Wei Z, Jiang X, Qiao H, Zhai B, Zhang L, Zhang Q, Wu Y, Jiang H, &, Sun X, (2013) STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells. Cell Signal 25, 931-938.
-
(2013)
Cell Signal
, vol.25
, pp. 931-938
-
-
Wei, Z.1
Jiang, X.2
Qiao, H.3
Zhai, B.4
Zhang, L.5
Zhang, Q.6
Wu, Y.7
Jiang, H.8
Sun, X.9
-
42
-
-
84859712679
-
Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin to treat hepatocellular carcinoma
-
He C, Sun XP, Qiao H, Jiang X, Wang D, Jin X, Dong X, Wang J, Jiang H, &, Sun X, (2012) Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin to treat hepatocellular carcinoma. Cancer Sci 103, 528-534.
-
(2012)
Cancer Sci
, vol.103
, pp. 528-534
-
-
He, C.1
Sun, X.P.2
Qiao, H.3
Jiang, X.4
Wang, D.5
Jin, X.6
Dong, X.7
Wang, J.8
Jiang, H.9
Sun, X.10
-
43
-
-
84867504415
-
Synergistic effects of ABT-737 and arsenic trioxide in inducing apoptosis of gastric cancer cells
-
Sun X-P, He C, Qiao H, Jiang X, Jiang H, &, Sun X, (2012) Synergistic effects of ABT-737 and arsenic trioxide in inducing apoptosis of gastric cancer cells. J Int Med Res 40, 1251-1264.
-
(2012)
J Int Med Res
, vol.40
, pp. 1251-1264
-
-
Sun, X.-P.1
He, C.2
Qiao, H.3
Jiang, X.4
Jiang, H.5
Sun, X.6
-
44
-
-
84874053045
-
Combination of albendazole and 2-methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice
-
Ehteda A, Galettis P, Pillai K, &, Morris DL, (2013) Combination of albendazole and 2-methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice. BMC Cancer 13, 86.
-
(2013)
BMC Cancer
, vol.13
, pp. 86
-
-
Ehteda, A.1
Galettis, P.2
Pillai, K.3
Morris, D.L.4
-
45
-
-
84865793850
-
Concomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer
-
Wang Q, Li SH, Wang H, Xiao Y, Sahin O, Brady SW, Li P, Ge H, Jaffee EM, Muller WJ, et al,. (2012) Concomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer. Cancer Res 72, 4417-4428.
-
(2012)
Cancer Res
, vol.72
, pp. 4417-4428
-
-
Wang, Q.1
Li, S.H.2
Wang, H.3
Xiao, Y.4
Sahin, O.5
Brady, S.W.6
Li, P.7
Ge, H.8
Jaffee, E.M.9
Muller, W.J.10
|